Abdelrahim, Maen

Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells. [electronic resource] - Molecular pharmacology Jun 2003 - 1373-81 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0026-895X

10.1124/mol.63.6.1373 doi


Aryl Hydrocarbon Receptor Nuclear Translocator
Breast Neoplasms--pathology
Cell Cycle--drug effects
DNA-Binding Proteins
Gene Silencing--drug effects
Humans
Lung Neoplasms--pathology
Polychlorinated Dibenzodioxins--toxicity
RNA, Small Interfering--pharmacology
Receptors, Aryl Hydrocarbon--genetics
Teratogens--toxicity
Transcription Factors--metabolism
Tumor Cells, Cultured